Company profile for GSK

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At GSK we have a challenging mission: to improve the quality of human life by enabling people to do more, feel better, live longer. Find out how this shapes everything we do, including our R&D, our partnerships, our work with communities and our efforts to prevent and treat disease around the world. We are a science-led global healthcare company with a mission: we want to help people to do more, feel better, live longer. The...
At GSK we have a challenging mission: to improve the quality of human life by enabling people to do more, feel better, live longer. Find out how this shapes everything we do, including our R&D, our partnerships, our work with communities and our efforts to prevent and treat disease around the world. We are a science-led global healthcare company with a mission: we want to help people to do more, feel better, live longer. The vaccines, medicines and consumer healthcare products that we research and develop can improve people’s health and well-being, ultimately helping them to live life to its fullest and contribute.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
980 Great West Road, Brentford, Middlesex TW8 9GS England
Telephone
Telephone
+44 (0)20 8047 5000
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

CPhI North America

Not Confirmed

envelop Contact Supplier

CPhI North America

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

INTERVIEW #SpeakPharma

[Sponsored by another company]
Alchem NicSelect™ grants customers royalty-free access to T-MAX™ tech for 3-in-1 vape satisfaction in flavour-restricted markets
With increasing flavour bans in key markets, vaping brands are facing significant challenges in providing satisfying alternatives to vapers and smokers looking to transition. Recognising this need, Alchem NicSelect™ is making a bold move by offering its key customers royalty-free and unrestricted geographical access to its revolutionary T-MAX™ technology.“At Alchem NicSelect™, we understand the urgency for vaping brands to adapt to new regulations without compromising on satisfaction. By offering royalty-free access to T-MAX™ technology, we empower our customers to provide the closest cigarette-like experience possible, even in markets with strict flavour restrictions,” said Riccardo Santambrogio, Europe Sales Manager.HIGHLIGHTS// offering royalty-free access to T-MAX™ technology/ unrestricted geographical access/ closest cigarette-like experience Addressing the biggest barrier: Nicotine satisfactionOne of the primary reasons many vapers are dissatisfied and smokers struggle to switch to vaping is that traditional nicotine solutions fail to replicate the rapid satisfaction provided by cigarettes. Nicotine replacement therapies (NRTs) and even conventional vaping products often lack the immediate nicotine hit, throat feel, and overall experience that smokers are accustomed to. T-MAX™ solves this problem by engineering a nicotine experience that closely mimics cigarette consumption without relying on flavours.T-MAX™ provides a unique 3-in-1 approach:1. The Speed of a Cigarette – Rapid nicotine delivery and rush within seconds for immediate satisfaction.2. The Power of Nicotine Salts – A stronger perceived nicotine effect without exceeding legal limits (20 mg/ml nicotine limit under the European Tobacco Products Directive). With T-MAX™, 8 mg/ml feels like 20 mg/ml, and 14 mg/ml feels like 40 mg/ml.3. The Throat Hit of Freebase Nicotine – Especially in a flavour-free formulation, the combined ingredients in T-MAX™ deliver an even more satisfying throat feel than expected from nicotine base, much closer to and more familiar with a cigarette throat feel that habitual smokers recognise.HIGHLIGHTS// unique 3-in-1 approach/ rush within seconds/ stronger perceived nicotine effect without exceeding legal limits/ more satisfying throat feel that habitual smokers recogniseNo flavour, but not less satisfyingWhile flavours have traditionally played a role in vaping adoption, market realities are shifting. With flavour bans spreading across regions, brands need solutions that deliver satisfaction without relying on taste. Consumer research has shown that T-MAX™ performs exceptionally well even without added flavours. Since most cigarette smokers do not smoke for the tobacco flavour but rather for the nicotine hit and habitual experience, T-MAX™ provides a viable alternative that aligns with new regulatory landscapes.HIGHLIGHTS// flavour bans spreading across regions/ T-MAX™ performs exceptionally well even without added flavoursEmpowering vape brands with free access to T-MAX™By granting customers royalty-free access to the T-MAX™ technology, Alchem NicSelect™ is removing barriers for vaping brands and original equipment manufacturers (OEMs) looking to adapt to regulatory changes. This open-access approach ensures that manufacturers can integrate T-MAX™ into their product lines without additional costs, allowing them to offer superior nicotine satisfaction in markets where flavours are no longer an option.HIGHLIGHTS// removing barriers for vaping brands and OEMs looking to adapt/ manufacturers can integrate T-MAX™ into product lines without additional costsThe future of vaping in restricted marketsWith T-MAX™, the vaping industry has a powerful tool to retain customers and convert smokers who have struggled with traditional vaping products. By delivering the key elements of cigarette satisfaction — without combustion or flavours — T-MAX™ is set to redefine what a satisfying vape experience means in a post-flavour-ban world.“Our commitment to innovation and accessibility means we are providing our customers with the solutions they need to navigate an evolving regulatory landscape. T-MAX™ allows brands to offer a highly satisfying experience that mimics smoking without relying on flavours. The message is clear: no flavour, but not less satisfying”, added Santambrogio.HIGHLIGHTS// powerful tool to retain customers and convert smokers/ delivering the key elements of cigarette satisfaction without combustion or flavours/ no flavour, but not less satisfying

Impressions: 274

https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets

Radio Compass
06 May 2025

VLOG #PharmaReel

[Sponsored by another company]
This PharmaReel highlights Transo-Pharm USA’s offerings of premium Phyto Cannabidiol (CBD) and Phyto Cannabigerol (CBG) isolates from its cGMP-certified facility inspected by the FDA and ANVISA. The company has an expanded reach across the US and EU.

Impressions: 332

read-more

DATA COMPILATION #PharmaFlow

[Sponsored by another company]
DMF filings surge 44% in Q1 2025; India tops list with 51% rise in year-on-year submissions
The first quarter (Q1) of 2025 witnessed an impressive surge in Drug Master File (DMF) submissions to the US Food and Drug Administration (FDA), signaling a robust expansion in pharmaceutical development activities, the looming threat of tariffs notwithstanding.A total of 339 Type II DMFs were submitted during this period, as opposed to 235 submissions in Q1 2024, marking an exceptional increase of 44.26 percent. PharmaCompass’ data suggests that this is a record high for any first quarter.Overall, 440 DMFs were submitted across all categories (Types II, III, IV, and V) during Q1 2025, compared to 353 in the same period last year — representing a 24.65 percent increase.India and China continued to dominate the DMF landscape. India led with 162 submissions in Q1 2025, posting a remarkable 51.4 percent increase over 107 submissions recorded in Q1 2024. China followed with 135 submissions, representing a 33.66 percent increase over the 101 filings in Q1 2024.Taiwan sprung a surprise as a distant third. It made 12 DMF submissions in Q1 2025, as opposed to just one in Q1 2024. Western countries like the US, Spain, Germany, and Italy have maintained relatively stable or declining submission rates. Only the Netherlands showed significant growth with four DMF submissions in Q1 2025, up from zero in Q1 2024. View FDA DMF Filings in Q1 2025 (Power BI Dashboard, Free Excel Available)Indian giants MSN, Aurobindo, Cipla, Dr Reddy’s lead record-breaking DMF surgeIndia lived up to its “pharmacy of the world” reputation with the highest DMF submissions. In fact, seven of the top eight companies in the DMF tally were headquartered in India. MSN Group, emerged as the unequivocal leader with 23 submissions in Q1 2025, as against 15 in Q1 2024. Aurobindo Pharma increased its DMF activity from seven submissions in Q1 2024 to 12 in Q1 2025. Alivus Life Sciences, formerly known as Glenmark, made a dramatic leap with eight submissions in Q1 2025, quadrupling its previous year’s count of just two. Cipla more than doubled its DMF submissions — from three in Q1 2024 to eight in Q1 2025.Dr. Reddy’s Laboratories, one of India’s largest generic drugmakers, filed seven DMF submissions. The company’s Q1 2025 DMF portfolio includes high-value molecules like deucravacitinib, finerenone, enzalutamide, niraparib tosylate monohydrate, tucatinib, and tizanidine hydrochloride.Dr. Reddy’s has also indicated that they are open to manufacturing in the US. Meanwhile, Hetero Drugs filed seven submissions while Lee Pharma recorded six in Q1 2025.Chinese manufacturer Jiangsu East-Mab Biomedical Technology also established a significant presence with six DMFs. View FDA DMF Filings in Q1 2025 (Power BI Dashboard, Free Excel Available) Semaglutide, finerenone see most DMF submissions; first-time filings surge 64%Semaglutide and finerenone emerged as the most documented molecules in Q1 2025, each garnering nine DMF submissions. Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that has revolutionized diabetes management and weight loss treatment, continues to attract significant manufacturer interest. Similarly, finerenone, a non-steroidal drug used in treating chronic kidney disease in type 2 diabetes patients, has garnered attention from manufacturers.Carfilzomib, used in multiple myeloma treatment, secured the third position with five DMF submissions. Deucravacitinib, a novel drug approved for moderate to severe plaque psoriasis, followed with four DMF submissions.There were several molecules with three DMF submissions each. Among them were tapinarof, a novel drug for psoriasis, and tirzepatide, a GLP-1/GIP receptor agonist that has shown remarkable efficacy in diabetes and weight management. During the quarter, 23 molecules received their inaugural DMF submissions. This number has risen by 64 percent since Q1 2024, when only 14 drugs saw their first DMF filings.In Q1 2025, these 23 first-time molecules collectively garnered 30 DMF submissions, with deucravacitinib emerging as the clear leader. Indian companies Dr. Reddy’s Laboratories and Cipla filed DMFs for this plaque psoriasis treatment as did Spain’s Curia and PMC Global.The Q1 2025 roster of first-time DMF filings include retatrutide (another GLP-1 receptor agonist), sotagliflozin, setmelanotide acetate, daridorexant, nusinersen, zavegepant, belzutifan, elacestrant dihydrochloride, selumetinib sulfate, sotorasib, atogepant, omadacycline tosylate, osilodrostat phosphate, ensifentrine, landiolol hydrochloride, maralixibat chloride, maribavir, methyl olivetolate, diazoxide choline, sparsentan, thinnertide, and vismodegib. View FDA DMF Filings in Q1 2025 (Power BI Dashboard, Free Excel Available) Our viewGiven Trump’s rhetoric around tariffs on imported drugs, the record-breaking DMF submissions in Q1 2025 sent out a strong message that the global pharmaceutical industry is willing to take on the complex geopolitical situation with resilience and strategic foresight.On a different note, the rise in DMF filings also indicate increased workload for the FDA staff, as also more inspections by the agency. It seems like more ‘laid off’ FDA employees will be asked to return to work in the coming days.

Impressions: 519

https://www.pharmacompass.com/radio-compass-blog/dmf-filings-surge-44-in-q1-2025-india-tops-list-with-51-rise-in-year-on-year-submissions

#PharmaFlow by PHARMACOMPASS
15 May 2025

NEWS #PharmaBuzz

read-more
read-more

https://www.gsk.com/en-gb/media/press-releases/gsk-to-acquire-efimosfermin-a-phase-iii-ready-potential-best-in-class-specialty-medicine-to-treat-and-prevent-progression-of-steatotic-liver-disease-sld/

PRESS RELEASE
15 May 2025

https://www.reuters.com/business/healthcare-pharmaceuticals/iteos-gsk-discontinue-lung-cancer-therapy-development-2025-05-13/

REUTERS
14 May 2025

https://www.indianpharmapost.com/news/glaxosmithkline-pharmaceuticals-posts-fy25-pat-at-rs-915-cr-17155

INDPHARMAPOST
14 May 2025

https://www.fiercepharma.com/pharma/fda-misses-another-approval-decision-deadline-time-gsks-nucala-copd

FIERCE PHARMA
09 May 2025

https://www.gsk.com/en-gb/media/press-releases/glisten-phase-iii-trial-results-show-linerixibat-significantly-improves-cholestatic-pruritus/

PRESS RELEASE
09 May 2025

https://www.fiercepharma.com/pharma/gsk-weathers-storm-slipping-vaccine-sales-it-lines-its-mitigation-options-potential-tariffs

FIERCE PHARMA
01 May 2025

Excipients

Click here to find the perfect excipient manufacturers by their capabilities

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Contact GlaxoSmithKline and get a quotation

GlaxoSmithKline is a supplier offers 142 products (APIs, Excipients or Intermediates).

Find a price of Cefuroxime Sodium bulk with DMF, CEP offered by GlaxoSmithKline

Find a price of Fluticasone Propionate bulk with DMF, CEP offered by GlaxoSmithKline

Find a price of Amoxicillin Trihydrate bulk with CEP offered by GlaxoSmithKline

Find a price of Betamethasone Valerate bulk with CEP offered by GlaxoSmithKline

Find a price of Ceftazidime bulk with CEP offered by GlaxoSmithKline

Find a price of Clavulanic Acid bulk with CEP offered by GlaxoSmithKline

Find a price of Clobetasol Propionate bulk with CEP offered by GlaxoSmithKline

Find a price of Salbutamol Sulphate bulk with CEP offered by GlaxoSmithKline

Find a price of Ceftazidime bulk with DMF offered by GlaxoSmithKline

Find a price of Cefuroxime Axetil bulk offered by GlaxoSmithKline

Find a price of Clavulanic Acid bulk offered by GlaxoSmithKline

Find a price of Fluticasone Furoate bulk with DMF offered by GlaxoSmithKline

Find a price of Fluticasone Propionate bulk with DMF offered by GlaxoSmithKline

Find a price of Griseofulvin bulk offered by GlaxoSmithKline

Find a price of Labetalol Hydrochloride bulk offered by GlaxoSmithKline

Find a price of Mupirocin Calcium bulk offered by GlaxoSmithKline

Find a price of Paroxetine Hydrochloride bulk with DMF offered by GlaxoSmithKline

Find a price of Salbutamol Sulphate bulk with DMF offered by GlaxoSmithKline

Find a price of Salmeterol Xinafoate bulk with DMF offered by GlaxoSmithKline

Find a price of Umeclidinium Bromide bulk with DMF offered by GlaxoSmithKline

Find a price of Vilanterol Trifenatate bulk with DMF offered by GlaxoSmithKline

Find a price of bulk with JDMF offered by GlaxoSmithKline

Find a price of 6-Aminopenicillanic Acid bulk offered by GlaxoSmithKline

Find a price of Albendazole bulk offered by GlaxoSmithKline

Find a price of Amoxicillin Sodium bulk offered by GlaxoSmithKline

Find a price of Amoxicillin Trihydrate bulk offered by GlaxoSmithKline

Find a price of Ampicillin bulk offered by GlaxoSmithKline

Find a price of Ampicillin Sodium bulk offered by GlaxoSmithKline

Find a price of Ampicillin Trihydrate bulk offered by GlaxoSmithKline

Find a price of Auranofin bulk offered by GlaxoSmithKline

Find a price of Beclomethasone Dipropionate bulk offered by GlaxoSmithKline

Find a price of Betamethasone Dipropionate bulk offered by GlaxoSmithKline

Find a price of Betamethasone Valerate bulk offered by GlaxoSmithKline

Find a price of Calcitonin bulk offered by GlaxoSmithKline

Find a price of Caramiphen Ethanedisulfonate bulk offered by GlaxoSmithKline

Find a price of Carbenicillin Indanyl bulk offered by GlaxoSmithKline

Find a price of Cephalexin bulk offered by GlaxoSmithKline

Find a price of Cephalosporin bulk offered by GlaxoSmithKline

Find a price of Cephradine bulk offered by GlaxoSmithKline

Find a price of Chlorpheniramine Maleate bulk offered by GlaxoSmithKline

Find a price of Cimetidine bulk offered by GlaxoSmithKline

Find a price of Clobetasol Propionate bulk offered by GlaxoSmithKline

Find a price of Clobetasone Butyrate bulk offered by GlaxoSmithKline

Find a price of Cloxacillin Benzathine bulk offered by GlaxoSmithKline

Find a price of Cloxacillin Sodium bulk offered by GlaxoSmithKline

Find a price of Deoxyuridine bulk offered by GlaxoSmithKline

Find a price of Diethylcarbamazine Citrate bulk offered by GlaxoSmithKline

Find a price of Diphenidol bulk offered by GlaxoSmithKline

Find a price of Diphenylpyraline bulk offered by GlaxoSmithKline

Find a price of Dopamine bulk offered by GlaxoSmithKline

Find a price of Doxepin Hydrochloride bulk offered by GlaxoSmithKline

Find a price of Fondaparinux Sodium bulk offered by GlaxoSmithKline

Find a price of Hydrochlorothiazide bulk offered by GlaxoSmithKline

Find a price of Isopropamide Iodide bulk offered by GlaxoSmithKline

Find a price of Liothyronine Sodium bulk offered by GlaxoSmithKline

Find a price of Megestrol Acetate bulk offered by GlaxoSmithKline

Find a price of Methicillin bulk offered by GlaxoSmithKline

Find a price of Mupirocin bulk offered by GlaxoSmithKline

Find a price of Nafcillin Sodium bulk offered by GlaxoSmithKline

Find a price of Oxacillin Sodium bulk offered by GlaxoSmithKline

Find a price of Paroxetine Hydrochloride bulk offered by GlaxoSmithKline

Find a price of Penicillin G Potassium bulk offered by GlaxoSmithKline

Find a price of Propyliodone bulk offered by GlaxoSmithKline

Find a price of Sodium Dicloxacillin bulk offered by GlaxoSmithKline

Find a price of Streptokinase bulk offered by GlaxoSmithKline

Find a price of Streptomycin bulk offered by GlaxoSmithKline

Find a price of Sucralfate bulk offered by GlaxoSmithKline

Find a price of Tetanus Immunoglobulin bulk offered by GlaxoSmithKline

Find a price of Ticarcillin bulk offered by GlaxoSmithKline

Find a price of Ticarcillin Monosodium bulk offered by GlaxoSmithKline

Find a price of Tranylcypromine Sulfate bulk offered by GlaxoSmithKline

Find a price of Trifluoperazine Hydrochloride bulk offered by GlaxoSmithKline

Find a price of Vitamin B12 bulk offered by GlaxoSmithKline

Find a price of Zidovudine bulk offered by GlaxoSmithKline

Find a price of O/4 DIHYDROCHLORIDE DIHYRATE (CPZ ROUTE) bulk offered by GlaxoSmithKline

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN BOMBAY, INDIA. bulk offered by GlaxoSmithKline

Find a price of FACILITY IN BUCKHAVEN, UNITED KINGDOM bulk offered by GlaxoSmithKline

Find a price of 0/4 DIHYDROCHLORIDE DIHYDRATE (CEPHALORIDINE ROUTE-CP)-ULVERSTON PLANT bulk offered by GlaxoSmithKline

Find a price of FACILITIES, METHODS AND CONTROLS bulk offered by GlaxoSmithKline

Find a price of FACILITIES UTILIZED IN WARE HERTS, UNITED KINGDOM bulk offered by GlaxoSmithKline

Find a price of FACILS AND GEN OPER PROCEDS AT THE ULVERSTON PLANT bulk offered by GlaxoSmithKline

Find a price of SYNTHESIS & QUALITY CONTROLS FOR 5,7-DICHLORO-8-HYDROXYQUINOLONE bulk offered by GlaxoSmithKline

Find a price of BRL 47539 (2-ACETOXYMETHYL-4-IODOBUT-1-YL-ACETATE) bulk offered by GlaxoSmithKline

Find a price of FACILITY LOCATED IN EDINBURG, SCOTLAND bulk offered by GlaxoSmithKline

Find a price of 'ZENTEL' 'TILTAB' TABLETS bulk offered by GlaxoSmithKline

Find a price of GENERAL OPERATING PROCEDURES FOR THE HEPPIGIES, BELGIUM--ANTIBIOTICS bulk offered by GlaxoSmithKline

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN CIDRA, PUERTO RICO. bulk offered by GlaxoSmithKline

Find a price of CHIMERIC (MACAQUE VARIABLE/HUMAN CONSTANT) (RECOMBINANT, CHO CELLS) MONOCLONAL ANTIBODY (SB 210396; CE9.1) TO HUMAN CD4 ANTIGEN bulk offered by GlaxoSmithKline

Find a price of HIV VACCINE (GPL 120/NEFTA/ASO2A) bulk offered by GlaxoSmithKline

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN GREENVILLE, NORTH CAROLINA. bulk offered by GlaxoSmithKline

Find a price of COMPOUND 904 bulk offered by GlaxoSmithKline

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL AND GENERAL OPERATING PROCEDURES IN SINGAPORE bulk offered by GlaxoSmithKline

Find a price of BUILDINGS AND FACILITIES IN SEALS SANDS, ENGLAND bulk offered by GlaxoSmithKline

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN MONTROSE, ANGEES, SCOTLAND. bulk offered by GlaxoSmithKline

Find a price of MFG. SITE FACILITIES UTILIZED IN SPEKE LIVERPOOL (UK) bulk offered by GlaxoSmithKline

Find a price of FACILITIES&CONTROLS AT HARLOW AND GREAT BURGH RESEARCH SITES, ENGLAND bulk offered by GlaxoSmithKline

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN CUERNAVACA, MEXICO. bulk offered by GlaxoSmithKline

Find a price of ENTRENOL bulk offered by GlaxoSmithKline

Find a price of FACIL, PERSONNEL AND GENERAL OPERATING PROCEDURES IN HARLOW, ESSEX. bulk offered by GlaxoSmithKline

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN CAROLINA, PUERTO RICO. bulk offered by GlaxoSmithKline

Find a price of FACILITIES & CONTROLS OF THE WELLCOME FOUNDATION IN KENT ENGLAND bulk offered by GlaxoSmithKline

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES. bulk offered by GlaxoSmithKline

Find a price of MFGR, CONTROL PROCEDURES & FACILITIES-MYERSTOWN, PA., PLANT bulk offered by GlaxoSmithKline

Find a price of MANUFACTURING SITE, FACILITIES, PESONNEL, AND GENERAL OPERATING PROCEDURES IN WEST SUSSEX, ENGLAND. bulk offered by GlaxoSmithKline

Find a price of FACILITIES AND OPERATING PROCEDURES IN TIANJIN, CHINA bulk offered by GlaxoSmithKline

Find a price of MANUFACTURING SITE AND FACILITIES FOR ANNAN, UK PLANT bulk offered by GlaxoSmithKline

Find a price of MFG. FACILITIES LOCATED IN JURONG, SINGAPORE bulk offered by GlaxoSmithKline

Find a price of 7-ACA TOSYLATE bulk offered by GlaxoSmithKline

Find a price of FACILITIES AND MANUFACTURING bulk offered by GlaxoSmithKline

Find a price of MANUFACTURING FACILITY AT VERONA, ITALY. bulk offered by GlaxoSmithKline

Find a price of PENN CHEMICALS PRODUCTION FACILITY IN COUNTY CORK, IRELAND bulk offered by GlaxoSmithKline

Find a price of GENERAL OPERATING PROCEDURES SINGAPORE PLANT bulk offered by GlaxoSmithKline

Find a price of MANUFACTURING PRODUCTION FACILITY IN TORONTO, CANADA bulk offered by GlaxoSmithKline

Find a price of FACIL, PERSONNEL & GENL OPER PROCED IN GREAT BURGH, EPSOM, U.K. bulk offered by GlaxoSmithKline

Find a price of CLENOLIXIMAB [CHIMERIC (MACAQUE/HUMAN) MONOCLONAL ANTIBODY (SB-217969) (CHO CELLS, SMITHKLINE BEECHAM) TO CD4] bulk offered by GlaxoSmithKline

Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN TONBRIDGE, KENT, ENGLAND. bulk offered by GlaxoSmithKline

Find a price of L-DM1 bulk offered by GlaxoSmithKline

Find a price of ASO1B ADJUVANT SYSTEM bulk offered by GlaxoSmithKline

Find a price of Abacavir Sulfate bulk offered by GlaxoSmithKline

Find a price of Benzyl Penicillin bulk offered by GlaxoSmithKline

Find a price of Cabotegravir bulk offered by GlaxoSmithKline

Find a price of Cabotegravir Sodium bulk offered by GlaxoSmithKline

Find a price of CAS 103639-04-9 bulk offered by GlaxoSmithKline

Find a price of Daprodustat bulk offered by GlaxoSmithKline

Find a price of Dolutegravir Sodium bulk offered by GlaxoSmithKline

Find a price of Dutasteride bulk offered by GlaxoSmithKline

Find a price of Epsiprantel bulk offered by GlaxoSmithKline

Find a price of Fluticasone Furoate bulk offered by GlaxoSmithKline

Find a price of Lacidipine bulk offered by GlaxoSmithKline

Find a price of Lamivudine bulk offered by GlaxoSmithKline

Find a price of Nabumetone bulk offered by GlaxoSmithKline

Find a price of Naratriptan Hydrochloride bulk offered by GlaxoSmithKline

Find a price of Nelarabine bulk offered by GlaxoSmithKline

Find a price of Ondansetron bulk offered by GlaxoSmithKline

Find a price of Pazopanib Hydrochloride bulk offered by GlaxoSmithKline

Find a price of Ranitidine Hydrochloride bulk offered by GlaxoSmithKline

Find a price of Retapamulin bulk offered by GlaxoSmithKline

Find a price of Trametinib bulk offered by GlaxoSmithKline

Find a price of Umeclidinium Bromide bulk offered by GlaxoSmithKline

Find a price of Vilanterol Trifenatate bulk offered by GlaxoSmithKline

Find a price of Zanamivir bulk offered by GlaxoSmithKline

Find a price of MEDICATED FEED bulk offered by GlaxoSmithKline

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty